Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MedImmune Restructures Vaccines Business | Contract Pharma

What are you searching for?

Sign in
Breaking News

MedImmune Restructures Vaccines Business

To close Mountain View and Santa Clara sites

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MedImmune, the global biologics arm of AstraZeneca, is restructuring its infectious disease and vaccines research, development and operations, resulting in the closure of its Mountain View, CA and Santa Clara, CA sites, and the consolidation of its infectious disease and vaccines research and development activities to other sites. The changes will be implemented in 2014.

MedImmune’s Hayward, CA site will remain open with additional capabilities invested there. The company estimates that approximately 300 positions will be impacted, with 100 positions moving to other locations, including the Hayward site. In February 2012, the company announced an efficiency program to improve productivity and cut costs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters